Brian G. Lloyd - May 7, 2021 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Brian G. Lloyd
Stock symbol
MMSI
Transactions as of
May 7, 2021
Transactions value $
-$224,500
Form type
4
Date filed
5/10/2021, 04:48 PM
Next filing
Sep 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Options Exercise $98.6K +5K +62.2% $19.72 13K May 7, 2021 Direct
transaction MMSI Common Stock, No Par Value Sale -$323K -5K -38.35% $64.62 8.04K May 7, 2021 Direct F1
transaction MMSI Common Stock, No Par Value Gift $0 -2.34K -29.15% $0.00 5.7K Apr 13, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -5K -100% $0.00* 0 May 7, 2021 Common Stock 5K $19.72 Direct F2
holding MMSI Non-qualified stock options (right to buy) 50K May 7, 2021 Common Stock 50K $28.20 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25K May 7, 2021 Common Stock 25K $44.80 Direct F4
holding MMSI Non-qualified stock options (right to buy) 30K May 7, 2021 Common Stock 30K $55.73 Direct F5
holding MMSI Non-qualified stock options (right to buy) 16.7K May 7, 2021 Common Stock 16.7K $37.71 Direct F6
holding MMSI Non-qualified stock options (right to buy) 9.68K May 7, 2021 Common Stock 9.68K $56.25 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.10, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Become exercisable in equal annual installments of 20% commencing on 05/02/2017.
F3 Become exercisable in equal annual installments of 20% commencing on 04/14/2018.
F4 Become exercisable in equal annual installments of 20% commencing on 03/02/2019.
F5 Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
F6 Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
F7 Become exercisable in equal annual installments of 25% commencing on 03/19/2022.